| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |